LINC00347: A Long Intergenic Non-Protein-Coding RNA (G338864)

Target Name: LINC00347

NCBI ID: G338864

LINC00347

Other Name(s): long intergenic non-protein coding RNA 347 | Long intergenic non-protein coding RNA 347, transcript variant 1

LINC00347: A Long Intergenic Non-Protein-Coding RNA

LINC00347 is a long non-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA has been shown to be involved in various cellular processes, including cell adhesion, migration, and transcriptional regulation. As a result, LINC00347 has potential as a drug target or biomarker.

Disegno

The discovery of LINC00347 was made using the latest sequencing technology, which has enabled researchers to identify a wide range of non-coding RNAs. LINC00347 was identified as a long non-coding RNA that was expressed in various tissues and cells, but its function and mechanism of action were not well understood.

Subsequent studies have demonstrated that LINC00347 plays a crucial role in cell adhesion and migration. LINC00347 has been shown to be involved in the formation of tight junctions, which are critical for maintaining tissue structure and function. Additionally, LINC00347 has been shown to be involved in the regulation of cell migration, which is essential for the development and maintenance of tissues and organs.

Furthermore, LINC00347 has been shown to have a negative impact on the expression of genes involved in cell proliferation and survival. This suggests that LINC00347 may be a potential drug target or biomarker for cancer.

Molecular Mechanism

The molecular mechanism of LINC00347 is not well understood, but it is known to be involved in the regulation of gene expression. LINC00347 is a long non-coding RNA that contains approximately 2000 exons, which makes it one of the longest known non-coding RNAs. It is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract.

Studies have shown that LINC00347 is involved in the regulation of gene expression by binding to specific DNA sequences and affecting the translation of RNA. Additionally, LINC00347 has been shown to play a role in the regulation of microRNA (miRNA) expression, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation.

Drug Targeting

LINC00347 has great potential as a drug target due to its involvement in various cellular processes that are important for human health. As mentioned earlier, LINC00347 is involved in cell adhesion and migration, which are critical for the development and maintenance of tissues and organs. Therefore, LINC00347 may be a potential target for drugs that are designed to modulate these processes.

Additionally, LINC00347 has been shown to play a role in the regulation of cell proliferation and survival, which are essential for the development and maintenance of tissues and organs. Therefore, LINC00347 may be a potential target for drugs that are designed to inhibit these processes.

Biomarker

LINC00347 has also been shown to have potential as a biomarker for various diseases, including cancer. The regulation of LINC00347 expression by miRNA has been shown to be involved in the development and progression of cancer. Therefore, LINC00347 may be a potential biomarker for cancer diagnosis and treatment.

Conclusion

In conclusion, LINC00347 is a long non-coding RNA that has been shown to play a crucial role in various cellular processes, including cell adhesion, migration, and transcriptional regulation. Its function and mechanism of action are not yet well understood, but its potential as a drug target or biomarker make it an attractive target for further study. Further research is needed to fully understand the role of LINC00347 in various biological processes and to develop safe and effective drugs that target this RNA.

Protein Name: Long Intergenic Non-protein Coding RNA 347

The "LINC00347 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00347 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets